Phase I/II study of ADXS11-001 or MEDI4736 immunotherapies alone and in combination, in patients with recurrent/metastatic cervical or human papillomavirus (HPV)-positive head and neck cancer

Detalles Bibliográficos
Autores principales: Cohen, Ezra EW, Moore, Kathleen N, Slomovitz, Brian M, Chung, Christine H, Anderson, Matthew L, Morris, Shannon R, Mauro, David, Burtness, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645484/
http://dx.doi.org/10.1186/2051-1426-3-S2-P147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645484/
http://dx.doi.org/10.1186/2051-1426-3-S2-P147

Ejemplares similares